Literature DB >> 1991272

The natural history of colorectal cancer. Opportunities for intervention.

S J Winawer1, A G Zauber, E Stewart, M J O'Brien.   

Abstract

There is now a better understanding of the natural history of colorectal cancer, which has provided a basis for intervention to influence outcome. The possible interventions include earlier detection of colorectal cancer, removal of premalignant adenomas, demonstration of the mucosal field defect that precedes neoplasia to evaluate baseline risk and its change with dietary modification, and identification of inherited and dietary risk factors. Five controlled trials evaluating early detection of colorectal cancer with fecal occult blood testing have enrolled more than 309,000 patients. Early stage cancers with improved survival has been observed, but data on mortality reduction have not as yet been reported. Studies of patients with adenomas have demonstrated high synchronous and metachronous rates as a basis for complete colon evaluation initially and a surveillance follow-up program. Hyperproliferation and lack of normal differentiation have been observed as a field defect in the colon preceding neoplasia. Inherited factors have recently been shown to be important in a larger proportion of individuals destined to develop colorectal adenomas and cancer. These observations of the natural history of colorectal cancer have provided new opportunities for the application of radiologic and endoscopic techniques in diagnosis and surveillance; each examination has its merit. Further research is needed to answer many critical questions that have been raised regarding the impact of these interventions.

Entities:  

Mesh:

Year:  1991        PMID: 1991272     DOI: 10.1002/1097-0142(19910215)67:4+<1143::aid-cncr2820671507>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

Review 1.  Colorectal cancer screening.

Authors:  R Scott Nelson; Alan G Thorson
Journal:  Curr Oncol Rep       Date:  2009-11       Impact factor: 5.075

2.  Avoidable delay in the management of carcinoma of the right colon.

Authors:  J F Stebbing; A G Nash
Journal:  Ann R Coll Surg Engl       Date:  1995-01       Impact factor: 1.891

3.  Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy.

Authors:  Aasma Shaukat; Timothy R Church; Ryan Shanley; Noah D Kauff; Michael J O'Brien; Glenn M Mills; Paul A Jordan; John A Allen; Adam Kim; Andrew D Feld; Ann Graham Zauber; Sidney J Winawer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-03-23       Impact factor: 4.254

4.  Comparison of p53 and bcl-2 expression in initial, synchronous, and metachronous colorectal adenomas.

Authors:  M Watatani; S Ieda; K Kuroda; H Inui; K Nishimura; M Yasutomi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Effect of comorbid conditions on adherence to colorectal cancer screening.

Authors:  Dana J Lukin; Lina H Jandorf; Rayhana J Dhulkifl; Linda D Thélémaque; Jennifer A Christie; Steven H Itzkowitz; Katherine N Duhamel
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

6.  Expression of 17-1A antigen and complement resistance factors CD55 and CD59 on liver metastasis in colorectal cancer.

Authors:  S B Hosch; P Scheunemann; M Lüth; S Inndorf; N H Stoecklein; A Erbersdobler; A Rehders; M Gundlach; W T Knoefel; J R Izbicki
Journal:  J Gastrointest Surg       Date:  2001 Nov-Dec       Impact factor: 3.452

7.  CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.

Authors:  Tadamichi Hamachi; Osamu Tajima; Kousaku Uezono; Shinji Tabata; Hiroshi Abe; Keizo Ohnaka; Suminori Kono
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

8.  Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.

Authors:  S Ganesh; C F Sier; M M Heerding; J H van Krieken; G Griffioen; K Welvaart; C J van de Velde; J H Verheijen; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 9.  Competition in Colon Cancer Screening? What Is the Role of Colonoscopy?

Authors:  Arthur Hoffman; Daniel Teubner; Ralf Kiesslich
Journal:  Viszeralmedizin       Date:  2014-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.